IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

5AM Venture Management, LLC

Q4 2023 Holdings

Filed 2024-02-14 | 25 holdings | $377.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Enliven Therapeutics Inc(ELVN)COM29337E102$71.4M5,160,97518.9%
Entrada Therapeutics Inc(TRDA)COM29384C108$66.5M4,408,37917.6%
Pharvaris N V(PHVS)COMN69605108$22.4M797,6005.9%
Celldex Therapeutics Inc New(CLDX)COM NEW15117B202$19.7M497,2705.2%
Moonlake Immunotherapeutics(MLTX)CLASS A ORD61559X104$18.3M302,6304.8%
Biohaven LTD(BHVN)COMG1110E107$17.1M399,9724.5%
Disc Medicine Inc(IRON)COM254604101$17.0M294,2214.5%
Dianthus Therapeutics Inc(DNTH)COM252828108$15.3M1,472,2644.1%
Merus N VCOMN5749R100$14.3M521,5313.8%
VOR Biopharma IncCOM929033108$14.3M6,361,7233.8%
Viridian Therapeutics Inc(VRDN)COM92790C104$12.8M586,5953.4%
Mirati Therapeutics Inc(MRTXEUR)COM60468T105$11.3M192,5003.0%
Viking Therapeutics Inc(VKTX)COM92686J106$10.9M585,0002.9%
Rallybio CorpCOM75120L100$8.7M3,630,7242.3%
Tyra Biosciences Inc(TYRA)COM90240B106$7.7M554,9792.0%
Anaptysbio Inc(ANAB)COM032724106$7.7M357,7332.0%
Scpharmaceuticals Inc(SCPH)COM810648105$7.5M1,200,6472.0%
Zentalis Pharmaceuticals Inc(ZNTL)COM98943L107$7.4M490,0002.0%
Spruce Biosciences IncCOM85209E109$6.9M2,364,0001.8%
Avidity Biosciences Inc(RNA)COM05370A108$6.0M665,5551.6%
Cogent Biosciences Inc(COGT)COM19240Q201$4.6M790,4401.2%
Mersana Therapeutics IncCOM59045L106$3.0M1,305,0000.8%
Homology Medicines IncCOM438083107$2.8M4,535,9190.7%
GH Research PLC(GHRS)ORDINARY SHARESG3855L106$2.3M404,4040.6%
Cidara Therapeutics IncCOM171757107$900.8K1,134,5110.2%